Neue ESH/ESC-Leitlinien für die arterielle Hypertonie: Was ist neu, und welche Indikation bleibt für die renale Denervierung?

P. Groha; S. Kufner; I. Ott; H. Schunkert

doi:10.1007/s00059-014-4178-y

Neue ESH/ESC-Leitlinien für die arterielle Hypertonie: Was ist neu, und welche Indikation bleibt für die renale Denervierung?

Translated title of the contribution: New ESH/ESC guidelines on arterial hypertension: What is new and what indications remain for renal denervation?

P. Groha
, S. Kufner
, I. Ott
, H. Schunkert

Clinic for Heart and Vascular Diseases

Technical University of Munich

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Abstract

Arterial hypertension is one of the most common diseases in the western world and one of the most important risk factors for other cardiovascular diseases. Despite widespread therapeutic options, there is still a large proportion of patients with uncontrolled hypertension. The new European guidelines on hypertension give clear lines of action for diagnosis and treatment sorted into appropriate evidence levels based on current scientific data. Such evidence is still unclear for renal denervation so that no clear recommendations can be given.

Translated title of the contribution	New ESH/ESC guidelines on arterial hypertension: What is new and what indications remain for renal denervation?
Original language	German
Pages (from-to)	952-956
Number of pages	5
Journal	Herz
Volume	39
Issue number	8
DOIs	https://doi.org/10.1007/s00059-014-4178-y
State	Published - Dec 2014

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1007/s00059-014-4178-y

Cite this

@article{c79e6205a3b740e5a38ab6c96f434521,

title = "Neue ESH/ESC-Leitlinien f{\"u}r die arterielle Hypertonie: Was ist neu, und welche Indikation bleibt f{\"u}r die renale Denervierung?",

abstract = "Arterial hypertension is one of the most common diseases in the western world and one of the most important risk factors for other cardiovascular diseases. Despite widespread therapeutic options, there is still a large proportion of patients with uncontrolled hypertension. The new European guidelines on hypertension give clear lines of action for diagnosis and treatment sorted into appropriate evidence levels based on current scientific data. Such evidence is still unclear for renal denervation so that no clear recommendations can be given.",

keywords = "Cardiovascular diseases, Diagnostics, Guidelines, High blood pressure, Therapy",

author = "P. Groha and S. Kufner and I. Ott and H. Schunkert",

note = "Publisher Copyright: {\textcopyright} 2014, Urban \& Vogel.",

year = "2014",

month = dec,

doi = "10.1007/s00059-014-4178-y",

language = "Deutsch",

volume = "39",

pages = "952--956",

journal = "Herz",

issn = "0340-9937",

publisher = "Springer Medizin",

number = "8",

}

TY - JOUR

T1 - Neue ESH/ESC-Leitlinien für die arterielle Hypertonie

T2 - Was ist neu, und welche Indikation bleibt für die renale Denervierung?

AU - Groha, P.

AU - Kufner, S.

AU - Ott, I.

AU - Schunkert, H.

PY - 2014/12

Y1 - 2014/12

N2 - Arterial hypertension is one of the most common diseases in the western world and one of the most important risk factors for other cardiovascular diseases. Despite widespread therapeutic options, there is still a large proportion of patients with uncontrolled hypertension. The new European guidelines on hypertension give clear lines of action for diagnosis and treatment sorted into appropriate evidence levels based on current scientific data. Such evidence is still unclear for renal denervation so that no clear recommendations can be given.

AB - Arterial hypertension is one of the most common diseases in the western world and one of the most important risk factors for other cardiovascular diseases. Despite widespread therapeutic options, there is still a large proportion of patients with uncontrolled hypertension. The new European guidelines on hypertension give clear lines of action for diagnosis and treatment sorted into appropriate evidence levels based on current scientific data. Such evidence is still unclear for renal denervation so that no clear recommendations can be given.

KW - Cardiovascular diseases

KW - Diagnostics

KW - Guidelines

KW - High blood pressure

KW - Therapy

UR - https://www.scopus.com/pages/publications/84922074101

U2 - 10.1007/s00059-014-4178-y

DO - 10.1007/s00059-014-4178-y

M3 - Artikel

C2 - 25384853

AN - SCOPUS:84922074101

SN - 0340-9937

VL - 39

SP - 952

EP - 956

JO - Herz

JF - Herz

IS - 8

ER -

Neue ESH/ESC-Leitlinien für die arterielle Hypertonie: Was ist neu, und welche Indikation bleibt für die renale Denervierung?

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this